Decision

Supplementary protection certificate for medicinal products (recast)

Effect: Passed
Result: 526 for · 23 against · 70 abstained roll call
Date: 28 February 2024, 12:51
Kind: New EU law · 1st reading

More facts (7)

Margin: by an overwhelming majority
Text: Report A-9-2024-0022
Dossier: 2023-0130
Source: Committee report
Votes: 4 votes · 1 roll call
Sitting: Wednesday 28 February 2024
Final vote: 164600

Margin: by an overwhelming majority
Text: Report A-9-2024-0022
Dossier: 2023-0130
Source: Committee report
Votes: 4 votes · 1 roll call
Sitting: Wednesday 28 February 2024
Final vote: 164600

Cite this page Roll-call results (EP)

Link to this page

Votes on this decision

Members on the final vote

Result

The final vote and what it means for this kind of decision.

Passed by an overwhelming majority.

Parliament adopted its position on the law.

Before the final vote, MEPs decided on 2 parts of the text voted on separately (1 adopted, 1 rejected).

Backed by The Left, S&D, Renew, EPP, ECR, Patriots and ESN; Greens mostly abstained.

Groups

Members counted in their current group: the view with groups at the date of the vote is not available right now.

Members’ votes by their current group. Majority: the most common position. Clear line: a position with at least two thirds of the group’s votes, otherwise Divided.
Group	For	Against	Abst.	Majority line	Clear line
The Left	For 8	Against 3	Abst. 1	Majority line For	Clear line For
Greens	For 2	Against 1	Abst. 26	Majority line Abstained	Clear line Abstained
S&D	For 60	Against 0	Abst. 0	Majority line For	Clear line For
Renew	For 38	Against 0	Abst. 0	Majority line For	Clear line For
EPP	For 91	Against 0	Abst. 1	Majority line For	Clear line For
ECR	For 22	Against 0	Abst. 2	Majority line For	Clear line For
Patriots	For 25	Against 0	Abst. 0	Majority line For	Clear line For
ESN	For 2	Against 0	Abst. 1	Majority line For	Clear line For
No group	For 2	Against 2	Abst. 1	Majority line Tie	Clear line Divided

Voted against their group, 0

Members who voted otherwise than a clear line (at least two thirds of the votes cast) of their group — groups as of today: the view with groups at the date of the vote is not available right now.

Nobody voted against a clear line of their group.

Countries

The final vote by national delegation.

The breakdown by country is not available right now.

Members

Each member’s recorded position on the final roll call — groups as of today: the view with groups at the date of the vote is not available right now.

Show all 619 members

Debate speakers and how they voted

The debate speakers are not available right now.

All votes on this decision, 4

In voting order. **Result**: for–against–abstained (a show of hands has no count). **Requested by**: the groups that asked for a roll call, a split vote or a separate vote.
No.	Vote	Recorded	Result
1	Amendments by the committee responsible — put to the vote collectively Amendments by the committee responsible – put to the vote collectively	Show of hands	Adopted
2	Separate vote on Article 26	Show of hands	Rejected
3	Separate vote on Article 26	Show of hands	Adopted
4	Final vote Certificat complémentaire de protection pour les médicaments (refonte) - Supplementary protection certificate for medicinal products (recast) - Ergänzendes Schutzzertifikat für Arzneimittel (Neufassung) - A9-0022/2024 - Tiemo Wölken - Proposition de la Commission	Roll call	526 for, 23 against, 70 abstained Adopted

Show the other 3 votesShow the other 0 votes

Votes on this decision, continued
No.	Vote	Recorded	Result
2	Separate vote on Article 26	Show of hands	Rejected
3	Separate vote on Article 26	Show of hands	Adopted
4	Final vote Certificat complémentaire de protection pour les médicaments (refonte) - Supplementary protection certificate for medicinal products (recast) - Ergänzendes Schutzzertifikat für Arzneimittel (Neufassung) - A9-0022/2024 - Tiemo Wölken - Proposition de la Commission	Roll call	526 for, 23 against, 70 abstained Adopted

Text

The text voted on.

Report A-9-2024-0022

The text in short Written by AI from the official text — check the source

Parliament's amended version of the Commission proposal for a regulation on the supplementary protection certificate for medicinal products (recast) sets out its first-reading position.

Read the text · Report a problem

Dossier

Where the dossier stands and its other decisions in plenary.

2023/0130(COD) · Ordinary legislative procedure

Parliament adopted its first-reading position on 28 February 2024. Next: negotiations with the Council, unless the Council accepts Parliament’s text as it stands.

Show the 6 steps of the dossier

Referred to committee · 11 September 2023 (done)
Committee work · Report adopted 24 January 2024 (done)
Tabled for plenary · 1 February 2024 (done)
Plenary vote · Adopted 28 February 2024 (done)
Negotiations with the Council (to come)
Published as law (to come)

Lead committee: JURI · Rapporteur: Tiemo WÖLKEN (S&D)

Connections

What this decision touches: the procedural chain, the same text, running issues, votes that split the chamber the same way.

No connections found for this decision.

Sources & citation

Where the facts on this page come from, and how to cite it.

Permalink: https://news.eu-parl.st-solutions.dev/decisions/2024-02-28/5
Official sources: Roll-call votes, sitting of 28 February 2024 (European Parliament)
Results of votes, sitting of 28 February 2024 (European Parliament)
Data source: EP Open Data API: decisions of the sitting MTG-PL-2024-02-28
Licensed CC BY 4.0.
Retrieved: 26 September 2026

Cite as

European Parliament (2024). “Supplementary protection certificate for medicinal products (recast)”. Decision, 28 February 2024. votingId 164600, document A-9-2024-0022, reference 2023-0130. EU Parl Watch Research. https://news.eu-parl.st-solutions.dev/decisions/2024-02-28/5 (retrieved 26 September 2026). Official sources: Roll-call votes, sitting of 28 February 2024 (European Parliament), https://www.europarl.europa.eu/doceo/document/PV-10-2024-02-28-RCV_EN.html; Results of votes, sitting of 28 February 2024 (European Parliament), https://www.europarl.europa.eu/doceo/document/PV-10-2024-02-28-VOT_EN.html. Data: EP Open Data API: decisions of the sitting MTG-PL-2024-02-28, https://data.europarl.europa.eu/api/v2/meetings/MTG-PL-2024-02-28/decisions?format=application%2Fld%2Bjson (CC BY 4.0).

BibTeX

@misc{epw-decision-2024-02-28-5,
  author = {{European Parliament}},
  title = {{Supplementary protection certificate for medicinal products (recast)}},
  year = {2024},
  date = {2024-02-28},
  howpublished = {\url{https://news.eu-parl.st-solutions.dev/decisions/2024-02-28/5}},
  url = {https://news.eu-parl.st-solutions.dev/decisions/2024-02-28/5},
  urldate = {2026-09-26},
  publisher = {EU Parl Watch Research},
  note = {Decision. votingId 164600, document A-9-2024-0022, reference 2023-0130. Official source: https://www.europarl.europa.eu/doceo/document/PV-10-2024-02-28-RCV\_EN.html, https://www.europarl.europa.eu/doceo/document/PV-10-2024-02-28-VOT\_EN.html. Data: EP Open Data API: decisions of the sitting MTG-PL-2024-02-28 (CC BY 4.0)}
}